Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial 2 (SPRINT 2)

NCT07146230 is registered in ClinicalTrials.gov with Montefiore Medical Center as lead sponsor.

NCT NCT07146230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07146230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial 2 (SPRINT 2)
Lead sponsor
Montefiore Medical Center
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
February 28, 2029
Enrollment
52 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer